222 related articles for article (PubMed ID: 18664619)
21. Frequent but borderline methylation of p16 (INK4a) and TIMP3 in medulloblastoma and sPNET revealed by quantitative analyses.
Mühlisch J; Bajanowski T; Rickert CH; Roggendorf W; Würthwein G; Jürgens H; Frühwald MC
J Neurooncol; 2007 May; 83(1):17-29. PubMed ID: 17206475
[TBL] [Abstract][Full Text] [Related]
22. Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort study.
Schwalbe EC; Lindsey JC; Nakjang S; Crosier S; Smith AJ; Hicks D; Rafiee G; Hill RM; Iliasova A; Stone T; Pizer B; Michalski A; Joshi A; Wharton SB; Jacques TS; Bailey S; Williamson D; Clifford SC
Lancet Oncol; 2017 Jul; 18(7):958-971. PubMed ID: 28545823
[TBL] [Abstract][Full Text] [Related]
23. A Novel Method for Rapid Molecular Subgrouping of Medulloblastoma.
Gómez S; Garrido-Garcia A; Garcia-Gerique L; Lemos I; Suñol M; de Torres C; Kulis M; Pérez-Jaume S; Carcaboso ÁM; Luu B; Kieran MW; Jabado N; Kozlenkov A; Dracheva S; Ramaswamy V; Hovestadt V; Johann P; Jones DTW; Pfister SM; Morales La Madrid A; Cruz O; Taylor MD; Martin-Subero JI; Mora J; Lavarino C
Clin Cancer Res; 2018 Mar; 24(6):1355-1363. PubMed ID: 29351917
[No Abstract] [Full Text] [Related]
24. HIF1A is Overexpressed in Medulloblastoma and its Inhibition Reduces Proliferation and Increases EPAS1 and ATG16L1 Methylation.
Cruzeiro GAV; Dos Reis MB; Silveira VS; Lira RCP; Carlotti CG; Neder L; Oliveira RS; Yunes JA; Brandalise SR; Aguiar S; Eterovic AK; Tone LG; Scrideli CA; Valera ET
Curr Cancer Drug Targets; 2018; 18(3):287-294. PubMed ID: 28302031
[TBL] [Abstract][Full Text] [Related]
25. Exploratory analysis of ERCC2 DNA methylation in survival among pediatric medulloblastoma patients.
Banfield E; Brown AL; Peckham EC; Rednam SP; Murray J; Okcu MF; Mitchell LE; Chintagumpala MM; Lau CC; Scheurer ME; Lupo PJ
Cancer Epidemiol; 2016 Oct; 44():161-166. PubMed ID: 27607585
[TBL] [Abstract][Full Text] [Related]
26. Genome-wide analysis of alternative splicing in medulloblastoma identifies splicing patterns characteristic of normal cerebellar development.
Menghi F; Jacques TS; Barenco M; Schwalbe EC; Clifford SC; Hubank M; Ham J
Cancer Res; 2011 Mar; 71(6):2045-55. PubMed ID: 21248070
[TBL] [Abstract][Full Text] [Related]
27. Hypermethylation of collagen α2 (I) gene (COL1A2) is an independent predictor of survival in head and neck cancer.
Misawa K; Kanazawa T; Misawa Y; Imai A; Endo S; Hakamada K; Mineta H
Cancer Biomark; 2011-2012; 10(3-4):135-44. PubMed ID: 22674299
[TBL] [Abstract][Full Text] [Related]
28. Dickkopf-1 is an epigenetically silenced candidate tumor suppressor gene in medulloblastoma.
Vibhakar R; Foltz G; Yoon JG; Field L; Lee H; Ryu GY; Pierson J; Davidson B; Madan A
Neuro Oncol; 2007 Apr; 9(2):135-44. PubMed ID: 17329407
[TBL] [Abstract][Full Text] [Related]
29. Aberrant hypermethylation of the major breakpoint cluster region in 17p11.2 in medulloblastomas but not supratentorial PNETs.
Frühwald MC; O'Dorisio MS; Dai Z; Rush LJ; Krahe R; Smiraglia DJ; Pietsch T; Elsea SH; Plass C
Genes Chromosomes Cancer; 2001 Jan; 30(1):38-47. PubMed ID: 11107174
[TBL] [Abstract][Full Text] [Related]
30. [Risk stratification in medulloblastoma: screening for molecular markers].
Ebinger M; Senf L; Scheurlen W
Klin Padiatr; 2006; 218(3):139-42. PubMed ID: 16688669
[TBL] [Abstract][Full Text] [Related]
31. ASC deficiency suppresses proliferation and prevents medulloblastoma incidence.
Knight ER; Patel EY; Flowers CA; Crowther AJ; Ting JP; Miller CR; Gershon TR; Deshmukh M
Oncogene; 2015 Jan; 34(3):394-402. PubMed ID: 24469054
[TBL] [Abstract][Full Text] [Related]
32. DNA methylation of developmental genes in pediatric medulloblastomas identified by denaturation analysis of methylation differences.
Diede SJ; Guenthoer J; Geng LN; Mahoney SE; Marotta M; Olson JM; Tanaka H; Tapscott SJ
Proc Natl Acad Sci U S A; 2010 Jan; 107(1):234-9. PubMed ID: 19966297
[TBL] [Abstract][Full Text] [Related]
33. Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features.
Kool M; Koster J; Bunt J; Hasselt NE; Lakeman A; van Sluis P; Troost D; Meeteren NS; Caron HN; Cloos J; Mrsić A; Ylstra B; Grajkowska W; Hartmann W; Pietsch T; Ellison D; Clifford SC; Versteeg R
PLoS One; 2008 Aug; 3(8):e3088. PubMed ID: 18769486
[TBL] [Abstract][Full Text] [Related]
34. Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations.
Thompson MC; Fuller C; Hogg TL; Dalton J; Finkelstein D; Lau CC; Chintagumpala M; Adesina A; Ashley DM; Kellie SJ; Taylor MD; Curran T; Gajjar A; Gilbertson RJ
J Clin Oncol; 2006 Apr; 24(12):1924-31. PubMed ID: 16567768
[TBL] [Abstract][Full Text] [Related]
35. Upregulation of SOX2, NOTCH1, and ID1 in supratentorial primitive neuroectodermal tumors: a distinct differentiation pattern from that of medulloblastomas.
Phi JH; Kim JH; Eun KM; Wang KC; Park KH; Choi SA; Kim YY; Park SH; Cho BK; Kim SK
J Neurosurg Pediatr; 2010 Jun; 5(6):608-14. PubMed ID: 20515335
[TBL] [Abstract][Full Text] [Related]
36. Deletion and aberrant CpG island methylation of Caspase 8 gene in medulloblastoma.
Gonzalez-Gomez P; Bello MJ; Inda MM; Alonso ME; Arjona D; Amiñoso C; Lopez-Marin I; de Campos JM; Sarasa JL; Castresana JS; Rey JA
Oncol Rep; 2004 Sep; 12(3):663-6. PubMed ID: 15289853
[TBL] [Abstract][Full Text] [Related]
37. Type I collagen is overexpressed in medulloblastoma as a component of tumor microenvironment.
Liang Y; Diehn M; Bollen AW; Israel MA; Gupta N
J Neurooncol; 2008 Jan; 86(2):133-41. PubMed ID: 17653508
[TBL] [Abstract][Full Text] [Related]
38. Identification of a novel homozygous deletion region at 6q23.1 in medulloblastomas using high-resolution array comparative genomic hybridization analysis.
Hui AB; Takano H; Lo KW; Kuo WL; Lam CN; Tong CY; Chang Q; Gray JW; Ng HK
Clin Cancer Res; 2005 Jul; 11(13):4707-16. PubMed ID: 16000565
[TBL] [Abstract][Full Text] [Related]
39. The RNA-binding protein Musashi1 affects medulloblastoma growth via a network of cancer-related genes and is an indicator of poor prognosis.
Vo DT; Subramaniam D; Remke M; Burton TL; Uren PJ; Gelfond JA; de Sousa Abreu R; Burns SC; Qiao M; Suresh U; Korshunov A; Dubuc AM; Northcott PA; Smith AD; Pfister SM; Taylor MD; Janga SC; Anant S; Vogel C; Penalva LO
Am J Pathol; 2012 Nov; 181(5):1762-72. PubMed ID: 22985791
[TBL] [Abstract][Full Text] [Related]
40. Mutations of the Wnt antagonist AXIN2 (Conductin) result in TCF-dependent transcription in medulloblastomas.
Koch A; Hrychyk A; Hartmann W; Waha A; Mikeska T; Waha A; Schüller U; Sörensen N; Berthold F; Goodyer CG; Wiestler OD; Birchmeier W; Behrens J; Pietsch T
Int J Cancer; 2007 Jul; 121(2):284-91. PubMed ID: 17373666
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]